Alpha-9 Oncology
Alpha-9 Oncology is a clinical-stage company developing radiopharmaceuticals to improve cancer treatment. They focus on creating bespoke molecules with optimal selectivity, stability, and payload delivery, advancing a robust pipeline of novel radiopharmaceuticals. Their systematic approach to molecule design allows for broad potential expansion into several validated oncology targets.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $175M
Date: 23-Oct-2024
Investors: Lightspeed Venture Partners, Ascenta Capital, General Catalyst, a16z Bio + Health, RA Capital Management, Janus Henderson Investors, Delos Capital, Digitalis Ventures, Lumira Ventures, abrdn Inc., Frazier Life Sciences, Longitude Capital, Nextech Invest, BVF Partners LP, Samsara BioCapital
Markets: Biotechnology, Oncology, Radiopharmaceuticals
HQ: Boston, Massachusetts, United States
Founded: 2018
Website: https://www.a9oncology.com/
Leave a Comment
Comments
No comments yet.